Stocks and Finance

MAP Pharmaceuticals

MAP Pharmaceuticals 3/27/2012

07:42 : JPMorgan tries to make sense out of all the drama with MAP Pharmaceuticals - JPMorgan tries to make sense out of all the drama with MAP Pharmaceuticals (MAPP), by taking the long view that Levadex is an "attractive, approvable product" despite missing out on first-pass FDA approval. Shares have been ...

Source : seekingalpha-com

06:34 : Shares of MAP Pharmaceuticals (MAPP) nosedive after coming off of a trading - Shares of MAP Pharmaceuticals (MAPP) nosedive after coming off of a trading halt and are now down 28.8% after ringing up a tidy AH gain yesterday. Though the company landed FDA approval for Levadex, a number of questions concerning ...

Source : seekingalpha-com

MAP Pharmaceuticals 3/26/2012

20:43 : MAP Pharmaceuticals (MAPP) says the FDA has issued a Complete Response ... - MAP Pharmaceuticals (MAPP) says the FDA has issued a Complete Response letter to its New Drug Application for Levadex. The FDA didn't cite clinical safety or efficacy issues, nor request any additional clinical studies be conducted ...

Source : seekingalpha-com

actualidad MAP Pharmaceuticals -